Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts

Rosanee W. Valyasevi, Debra A. Harteneck, Charyl M. Dutton, Rebecca S. Bahn

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

The symptoms and signs of Graves' ophthalmopathy (GO) result from both an accumulation of hydrated hyaluronan in the orbital muscles and connective tissues and an expansion of the orbital adipose tissues. Recent studies have suggested a link between the stimulation of adipogenesis within the orbit in GO and the expression in these tissues of TSH receptor (TSHR), the putative orbital autoantigen. To further investigate this association, we treated orbital fibroblasts from patients with GO with rosiglitazone, a thiazolidinedione agonist of the PPARγ receptor that stimulates adipocyte differentiation. We found this compound to be a potent stimulator of functional TSHR expression as well as TSHR and PPARγ mRNA levels in differentiated cultures. In addition, rosiglitazone treatment stimulated recruitment and differentiation of a subset of cells within these cultures into mature lipid-laden adipocytes. These results suggest that TSHR expression in GO orbital preadipocyte fibroblasts is linked to adipogenesis, and that ligation of the PPARγ receptor results in differentiation of these cells. It is possible that endogenous PPARγ ligands play a role in stimulating orbital adipogenesis in GO, and that future treatments may be aimed at antagonism of various components of the PPARγ signaling system.

Original languageEnglish (US)
Pages (from-to)2352-2358
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume87
Issue number5
DOIs
StatePublished - 2002

Fingerprint

Graves Ophthalmopathy
Thyrotropin Receptors
Adipogenesis
Peroxisome Proliferator-Activated Receptors
Fibroblasts
rosiglitazone
Tissue
Adipocytes
Tissue Expansion
Autoantigens
Orbit
Hyaluronic Acid
Connective Tissue
Signs and Symptoms
Ligation
Muscle
Adipose Tissue
Cell Differentiation
Orbits
Cell Culture Techniques

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts. / Valyasevi, Rosanee W.; Harteneck, Debra A.; Dutton, Charyl M.; Bahn, Rebecca S.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 87, No. 5, 2002, p. 2352-2358.

Research output: Contribution to journalArticle

@article{45bd062c18294e088e0ec2e603a018f1,
title = "Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts",
abstract = "The symptoms and signs of Graves' ophthalmopathy (GO) result from both an accumulation of hydrated hyaluronan in the orbital muscles and connective tissues and an expansion of the orbital adipose tissues. Recent studies have suggested a link between the stimulation of adipogenesis within the orbit in GO and the expression in these tissues of TSH receptor (TSHR), the putative orbital autoantigen. To further investigate this association, we treated orbital fibroblasts from patients with GO with rosiglitazone, a thiazolidinedione agonist of the PPARγ receptor that stimulates adipocyte differentiation. We found this compound to be a potent stimulator of functional TSHR expression as well as TSHR and PPARγ mRNA levels in differentiated cultures. In addition, rosiglitazone treatment stimulated recruitment and differentiation of a subset of cells within these cultures into mature lipid-laden adipocytes. These results suggest that TSHR expression in GO orbital preadipocyte fibroblasts is linked to adipogenesis, and that ligation of the PPARγ receptor results in differentiation of these cells. It is possible that endogenous PPARγ ligands play a role in stimulating orbital adipogenesis in GO, and that future treatments may be aimed at antagonism of various components of the PPARγ signaling system.",
author = "Valyasevi, {Rosanee W.} and Harteneck, {Debra A.} and Dutton, {Charyl M.} and Bahn, {Rebecca S.}",
year = "2002",
doi = "10.1210/jc.87.5.2352",
language = "English (US)",
volume = "87",
pages = "2352--2358",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts

AU - Valyasevi, Rosanee W.

AU - Harteneck, Debra A.

AU - Dutton, Charyl M.

AU - Bahn, Rebecca S.

PY - 2002

Y1 - 2002

N2 - The symptoms and signs of Graves' ophthalmopathy (GO) result from both an accumulation of hydrated hyaluronan in the orbital muscles and connective tissues and an expansion of the orbital adipose tissues. Recent studies have suggested a link between the stimulation of adipogenesis within the orbit in GO and the expression in these tissues of TSH receptor (TSHR), the putative orbital autoantigen. To further investigate this association, we treated orbital fibroblasts from patients with GO with rosiglitazone, a thiazolidinedione agonist of the PPARγ receptor that stimulates adipocyte differentiation. We found this compound to be a potent stimulator of functional TSHR expression as well as TSHR and PPARγ mRNA levels in differentiated cultures. In addition, rosiglitazone treatment stimulated recruitment and differentiation of a subset of cells within these cultures into mature lipid-laden adipocytes. These results suggest that TSHR expression in GO orbital preadipocyte fibroblasts is linked to adipogenesis, and that ligation of the PPARγ receptor results in differentiation of these cells. It is possible that endogenous PPARγ ligands play a role in stimulating orbital adipogenesis in GO, and that future treatments may be aimed at antagonism of various components of the PPARγ signaling system.

AB - The symptoms and signs of Graves' ophthalmopathy (GO) result from both an accumulation of hydrated hyaluronan in the orbital muscles and connective tissues and an expansion of the orbital adipose tissues. Recent studies have suggested a link between the stimulation of adipogenesis within the orbit in GO and the expression in these tissues of TSH receptor (TSHR), the putative orbital autoantigen. To further investigate this association, we treated orbital fibroblasts from patients with GO with rosiglitazone, a thiazolidinedione agonist of the PPARγ receptor that stimulates adipocyte differentiation. We found this compound to be a potent stimulator of functional TSHR expression as well as TSHR and PPARγ mRNA levels in differentiated cultures. In addition, rosiglitazone treatment stimulated recruitment and differentiation of a subset of cells within these cultures into mature lipid-laden adipocytes. These results suggest that TSHR expression in GO orbital preadipocyte fibroblasts is linked to adipogenesis, and that ligation of the PPARγ receptor results in differentiation of these cells. It is possible that endogenous PPARγ ligands play a role in stimulating orbital adipogenesis in GO, and that future treatments may be aimed at antagonism of various components of the PPARγ signaling system.

UR - http://www.scopus.com/inward/record.url?scp=0036096041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036096041&partnerID=8YFLogxK

U2 - 10.1210/jc.87.5.2352

DO - 10.1210/jc.87.5.2352

M3 - Article

C2 - 11994387

AN - SCOPUS:0036096041

VL - 87

SP - 2352

EP - 2358

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -